Clinical trial
Extension Study of Gelesis100 on Body Weight
NCT03021291 · Gelesis, Inc., Industry · Completed
Key facts
| NCT number | NCT03021291 |
|---|---|
| Title | Extension Study of Gelesis100 on Body Weight |
| Official title | An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04) |
| Acronym | GLOW-EX |
| Lead sponsor | Gelesis, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Overweight and Obesity |
| Intervention type | Device |
| Interventions | Gelesis100 (2.25 g) |
| Enrollment | 36 |
| Start date | Jan 25, 2017 |
| Primary completion | Dec 8, 2017 |
| Completion | Dec 15, 2017 |
| First posted | Jan 13, 2017 |
| Last update posted | Feb 22, 2018 |
| Countries | Czechia, Denmark, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: